Friday File: U Are Going To Like This

The holidays are coming and most of the world is already checked out. 

And we’re not going to be long here today either. 

But there’s some good things coming together and we’re glad you’re on board. 

The first is uranium.

In last week’s Uranium Breakout Confirmed After 15-Year Slumber we featured a uranium miner that could really make the most of the uranium bull market. 

This week it got even better. 

The company announced it would be opening multiple new mines as uranium prices continued to rise this week. 

Much more to come on that next year. 

On top of that, there are the GLP-1 agonist drugs like Ozempic.

The hype is more than real.

Novo Nordisk (NVO) is up 52% in the last year and Eli Lilly (LLY) is up 58%. 

Big moves for companies as big as they are. 

But they’re even bigger against the backdrop of a largely unwinding bubble for pharmaceutical stocks.

More to come in this sector in the future too.

Finally, we’ve got one more new play coming next week. 

It will be our top “contrarian” call for the year. 

A year ago we warned about the lithium market and, since then, it has gotten crushed. 

You can find lithium prices down 80% or more depending on the market.

Bubbles come. Bubbles go. And 2024 will have the same. You just have to make sure you’re on the right side of them.

That’s what we’ll try to do again.

All the best,

Andrew Mickey
Managing Editor, Shareholder Intel Action